Ernexa Therapeutics Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
Ernexa Therapeutics Inc. (ERNA) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $113.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-06
- Ernexa Therapeutics Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $35.00K, a 7.89% decline year-over-year.
- Ernexa Therapeutics Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $78.00K, a 52.94% increase year-over-year.
- Ernexa Therapeutics Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $56.00K, a 14.29% increase year-over-year.
- Ernexa Therapeutics Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $53.00K, a 87.20% decline year-over-year.
- Ernexa Therapeutics Inc. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $198.00K, a 86.79% decline from fiscal 2024.
- Ernexa Therapeutics Inc. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $1.50M, a 44.27% increase from fiscal 2023.
- Ernexa Therapeutics Inc. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $1.04M, a 209.23% increase from fiscal 2022.
- Ernexa Therapeutics Inc. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $336.00K, a 1.75% decline from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month as first filed | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month as first filed | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month as first filed | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $113.00K 10-Q · filed 2026-08-06 | $169.00K derived: sum of 3 quarters · filed 2026-08-06 | $222.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $78.00K 10-Q · filed 2026-05-11 | $134.00K derived: sum of 2 quarters · filed 2026-05-11 | $187.00K derived: sum of 3 quarters · filed 2026-05-11 | $225.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $109.00K derived: sum of 2 quarters · filed 2026-03-13 | $147.00K derived: sum of 3 quarters · filed 2026-08-06 | $198.00K 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $91.00K derived: sum of 2 quarters · filed 2026-08-06 | $142.00K 10-Q · filed 2025-11-07 | $191.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $89.00K 10-Q · filed 2026-08-06 | $138.00K derived: sum of 3 quarters · filed 2026-08-06 | $552.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $51.00K 10-Q · filed 2026-05-11 | $100.00K derived: sum of 2 quarters · filed 2026-05-11 | $514.00K derived: sum of 3 quarters · filed 2026-05-11 | $1.05M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $463.00K derived: sum of 2 quarters · filed 2026-03-13 | $997.00K derived: sum of 3 quarters · filed 2026-03-13 | $1.50M 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | $414.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $948.00K derived: sum of 2 quarters · filed 2025-11-07 | $1.45M 10-Q · filed 2025-11-07 | $1.91M derived: sum of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | $534.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $1.04M 10-Q · filed 2025-08-13 | $1.50M derived: sum of 3 quarters · filed 2025-08-13 | $1.99M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $502.00K 10-Q · filed 2025-05-07 | $961.00K derived: sum of 2 quarters · filed 2025-05-07 | $1.46M derived: sum of 3 quarters · filed 2025-05-07 | $1.50M derived: sum of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | $459.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $956.00K derived: sum of 2 quarters · filed 2025-03-12 | $998.00K derived: sum of 3 quarters · filed 2025-03-12 | $1.04M 10-K · filed 2025-03-12 | ||||
| 2023-09-30 | $497.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $539.00K derived: sum of 2 quarters · filed 2024-11-12 | $580.00K 10-Q · filed 2024-11-12 | $649.00K derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $83.00K 10-Q · filed 2024-08-13 | $152.00K derived: sum of 3 quarters · filed 2024-08-13 | $233.00K derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $41.00K 10-Q · filed 2024-05-14 | $110.00K derived: sum of 2 quarters · filed 2024-05-14 | $191.00K derived: sum of 3 quarters · filed 2024-05-14 | $275.00K derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $150.00K derived: sum of 2 quarters · filed 2024-03-14 | $234.00K derived: sum of 3 quarters · filed 2024-03-14 | $336.00K 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | $81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $165.00K derived: sum of 2 quarters · filed 2023-11-13 | $267.00K 10-Q · filed 2023-11-13 | $366.00K derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $84.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $186.00K 10-Q · filed 2023-08-11 | $285.00K derived: sum of 3 quarters · filed 2023-08-11 | $379.00K derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $102.00K 10-Q · filed 2023-05-11 | $201.00K derived: sum of 2 quarters · filed 2023-05-11 | $295.00K derived: sum of 3 quarters · filed 2023-05-11 | $374.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $99.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $193.00K derived: sum of 2 quarters · filed 2023-03-20 | $272.00K derived: sum of 3 quarters · filed 2023-03-20 | $342.00K 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | $94.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $173.00K derived: sum of 2 quarters · filed 2022-11-14 | $243.00K 10-Q · filed 2022-11-14 | $242.85K 10-Q · filed 2021-11-12 | $243.00K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $149.00K 10-Q · filed 2022-08-11 | $148.70K 10-Q · filed 2021-08-13 | $149.00K derived: sum of 3 quarters · filed 2022-08-11 | $149.00K derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $70.00K 10-Q · filed 2022-07-01 | $69.61K 10-Q · filed 2021-05-17 | $70.00K derived: sum of 2 quarters · filed 2022-07-01 | $70.00K derived: sum of 3 quarters · filed 2022-07-01 | $70.00K derived: sum of 4 quarters · filed 2022-07-01 | |||
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-01 | $0.00 derived: sum of 2 quarters · filed 2022-07-01 | $0.00 derived: sum of 3 quarters · filed 2022-07-01 | $0.00 10-K/A · filed 2022-07-01 | $173.00K 10-K · filed 2021-03-11 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | $161.00K 10-Q · filed 2020-11-13 | $74.00K derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $0.00 10-Q · filed 2021-08-13 | $146.00K 10-Q · filed 2020-08-07 | $74.00K derived: sum of 3 quarters · filed 2021-08-13 | $147.00K derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-17 | $73.00K 10-Q · filed 2020-05-20 | $74.00K derived: sum of 2 quarters · filed 2021-05-17 | $147.00K derived: sum of 3 quarters · filed 2021-05-17 | $219.00K derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $147.00K derived: sum of 2 quarters · filed 2021-03-11 | $219.00K derived: sum of 3 quarters · filed 2021-03-11 | $291.00K 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $73.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $145.00K derived: sum of 2 quarters · filed 2020-11-13 | $217.00K 10-Q · filed 2020-11-13 | |||||
| 2019-06-30 | $72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $144.00K 10-Q · filed 2020-08-07 | ||||||
| 2019-03-31 | $72.00K 10-Q · filed 2020-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |